Showing 1 - 1 of 1
In a pharmaceuticals Reference Price Scheme (RPS), firms are free to set their prices, but the (insured) consumer pays only the difference between the Reference level (R) and the actual price of the drug, if this is higher than R.By introducing n (1) firms with infinite cross-price elasticity...
Persistent link: https://www.econbiz.de/10014201483